Home Tags Intensity Therapeutics
Tag: Intensity Therapeutics
“Finding improved therapies for this disease is a critical unmet medical need,” said Lewis H. Bender, president and CEO of Intensity Therapeutics.
“We look forward to further evaluating the safety and efficacy of INT230-6,” says Intensity Therapeutics Founder and CEO Lewis Bender.
The targeted treatment is designed to work on breast, colon, pancreatic, liver, lung and other cancers that do not respond to conventional treatments.